First step toward new treatment for dangerous pregnancy complication
NCT ID NCT07327255
Summary
This early study is testing the safety of an experimental injection called EG-101 in healthy women. The goal is to gather initial safety data before testing the drug in pregnant women with severe pre-eclampsia, a serious condition that can threaten the lives of both mother and baby. Researchers will give 24 healthy volunteers different doses and closely monitor how their bodies react.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRE-ECLAMPSIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.